Download PDF
Drug Res (Stuttg) 2018; 68(10): 545-552
DOI: 10.1055/a-0582-9372
Review
© Georg Thieme Verlag KG Stuttgart · New York

Strategies in Development and Delivery of Nanotechnology Based Cosmetic Products

Usama Ahmad
1   Department of Pharmaceutics, Faculty of Pharmacy, Integral University, Lucknow, India
,
Zeeshan Ahmad
1   Department of Pharmaceutics, Faculty of Pharmacy, Integral University, Lucknow, India
,
Ahmed Abdullah Khan
1   Department of Pharmaceutics, Faculty of Pharmacy, Integral University, Lucknow, India
,
Juber Akhtar
1   Department of Pharmaceutics, Faculty of Pharmacy, Integral University, Lucknow, India
,
Satya Prakash Singh
1   Department of Pharmaceutics, Faculty of Pharmacy, Integral University, Lucknow, India
,
Farhan Jalees Ahmad
2   Department of Pharmaceutics, Jamia Hamdard, New Delhi, India
› Author Affiliations
Further Information

Publication History

received 22 September 2017

accepted 22 February 2018

Publication Date:
26 March 2018 (online)

Also available at
    Permissions and Reprints

Abstract

The science of formulation involving cosmetic ingredients has always been a challenge since the release of active components greatly depends upon the carrier system involved and the selectivity of skin barrier. The principle obstacle of the skin resides in the epidermis and it’s hard for many active components to cross it. The formulation related factors like size of particles, viscosity and lipophilicity of the components also play an important role in permeation of the dermal composition. Though widely used; conventional creams and gels still struggle in terms of success. This work focuses on nano based formulation strategies for successful delivery of cosmetic agents. Novel strategies like nanoemulsion, nanogels, liposomes, aquasomes, niosomes, dendrimers and fullerenes have paved way for successful delivery of dermal formulations to desire depths in the skin.

Key words

cosmetics - nanotechnology - skin barrier - microencapsulation
 

  • References

  • 1 Stevenson A, Waite M. Eds. Concise Oxford English Dictionary: Book & CD-ROM Set. Oxford University Press; 2011
    Google Scholar
  • 2 Oumeish OY. The cultural and philosophical concepts of cosmetics in beauty and art through the medical history of mankind. Clinics in dermatology 2001; 19: 375-386
    CrossrefPubMedGoogle Scholar
  • 3 Lucas A. Cosmetics, perfumes and incense in ancient Egypt. The Journal of Egyptian Archaeology 1930; 16: 41-53
    CrossrefPubMedGoogle Scholar
  • 4 Dureja H, Kaushik D, Gupta M. et al. Cosmeceuticals: An Emerging Concept. Indian J Pharmacol. 2005; 37: 155-159
    CrossrefPubMedGoogle Scholar
  • 5 Fornara CW. The nature of history in ancient Greece and Rome. Univ of California Press; 1988
    Google Scholar
  • 6 U.S. Food and Drug Administration. “Is it a cosmetic, a drug, or both? (Oris it soap?),” http://www.fda.gov/cosmetics/guidancecomplianceregulatoryinformation/ucm074201.htm
    PubMed
  • 7 Kligman AM. Cosmetics: A dermatologist looks to the future: promises and problems. Dermatologic clinics. 2000; 18: 699-709
    PubMedGoogle Scholar
  • 8 Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. European Journal of Pharmaceutical Sciences. 2013; 48: 416-427
    CrossrefPubMedGoogle Scholar
  • 9 NNI. National nanotechnology initiative: Research and development leading to a revolution in technology and industry. Washington, DC, USA: office of sciences and technology policy; 2005. http://www.nano.gov/nanotech-101/what
    Google Scholar
  • 10 SCCP (Scientific Committee on Consumer Products). Opinion on Safety of Nanomaterials in Cosmetic Products. European Union: 2007. p.5, 10
    PubMed
  • 11 Wester RC, Maibach HI. Structure-activity correlations in percutaneous absorption. In: Bronaugh RL. 9 Mmbach HI eds. Percutaneous absorption. Mechanisms, methodology, drug delivery. New York: Marcel Dekker; 1985: 107-123
    Google Scholar
  • 12 Behl CR, Flynn GL, Kurihara T. et al. Hydration and percutaneous absorption: I. Influence of hydration on alkanol permeation through hairless mouse skin. Journal of Investigative Dermatology 1980; 75: 346-352
    CrossrefPubMedGoogle Scholar
  • 13 Marwah H, Garg T, Goyal AK. et al. 2016; Permeation enhancer strategies in transdermal drug delivery. Drug delivery 23: 564-578
    CrossrefPubMedGoogle Scholar
  • 14 Riegelman S. Pharmacokinetics; Pharmacokinetic factors affecting epidermal penetration and percutaneous absorption. Clinical Pharmacology & Therapeutics 1974; 16 5part2 873-883
    CrossrefPubMedGoogle Scholar
  • 15 Liao AH, Ho HC, Lin YC. et al. Effects of microbubble size on ultrasound-induced transdermal delivery of high-molecular-weight drugs. PloS one 2015; 10: e0138500
    CrossrefPubMedGoogle Scholar
  • 16 Bronaugh RL, Maibach HI. Percutaneous absorption: Mechanisms–methodology–drug delivery. Marcel Dekker Inc;; 1989
    Google Scholar
  • 17 Wiechers JW. The barrier function of the skin in relation to percutaneous absorption of drugs. Pharmacy World & Science 1989; 11: 185-198
    PubMedGoogle Scholar
  • 18 Paolino D, Muzzalupo R, Ricciardi A. et al. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery. Biomedical microdevices 2007; 9: 421-433
    CrossrefPubMedGoogle Scholar
  • 19 Esposito E, Cortesi R, Drechsler M. et al. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharmaceutical research 2005; 22: 2163-2173
    CrossrefPubMedGoogle Scholar
  • 20 Kwon TK, Lee HY, Dai Kim J. et al. In vitro skin permeation of cubosomes containing water soluble extracts of Korean barberry. Colloid journal 2010; 72: 205-210
    CrossrefPubMedGoogle Scholar
  • 21 Rubio L, Alonso C, Rodríguez G. et al. Bicellar systems for in vitro percutaneous absorption of diclofenac. International journal of pharmaceutics 2010; 386: 108-113
    CrossrefPubMedGoogle Scholar
  • 22 Honeywell-Nguyen PL, Gooris GS, Bouwstra JA. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. Journal of investigative dermatology 2004; 123: 902-910
    CrossrefPubMedGoogle Scholar
  • 23 Kim JC. In vivo hair re-growth efficacies of minoxidil preparations: Distearyldimethylammonium chloride vesicles, cellulose acetate phthalate microparticles, and poloxamer solution. Journal of Drug Delivery Science and Technology. 2009; 19: 343-346
    CrossrefPubMedGoogle Scholar
  • 24 Lopes LB, Ferreira DA, de Paula D. et al Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: In vitro and in vivo skin penetration of cyclosporin A. Pharmaceutical research 2006; 23: 1332-1342
    CrossrefPubMedGoogle Scholar
  • 25 Maali A, Mosavian MH. Preparation and application of nanoemulsions in the last decade (2000–2010). Journal of Dispersion Science and Technology. 2013; 34: 92-105
    CrossrefPubMedGoogle Scholar
  • 26 Guglielmini G. Nanostructured novel carrier for topical application. Clinics in dermatology 2008; 26: 341-346
    PubMedGoogle Scholar
  • 27 Mason TG, Wilking JN, Meleson K. et al. Nanoemulsions: Formation, structure, and physical properties. Journal of Physics: Condensed Matter 2006; 18: R635
    CrossrefPubMedGoogle Scholar
  • 28 Ali A, Ansari VA, Ahmad U et al. Nanoemulsion: An Advanced Vehicle For Efficient Drug Delivery. Drug Research 2017
    PubMed
  • 29 McClements DJ. Nanoemulsions versus microemulsions: Terminology, differences, and similarities. Soft matter 2012; 8: 1719-1729
    CrossrefPubMedGoogle Scholar
  • 30 Yang Y, Marshall-Breton C, Leser ME. et al. Fabrication of ultrafine edible emulsions: Comparison of high-energy and low-energy homogenization methods. Food Hydrocolloids. 2012; 29: 398-406
    CrossrefPubMedGoogle Scholar
  • 31 Ahmad U, Akhtar J, Singh SP. et al. Silymarin nanoemulsion against human hepatocellular carcinoma: development and optimization. Artificial Cells, Nanomedicine, and Biotechnology 2017; 1-11
    PubMedGoogle Scholar
  • 32 Sonneville-Aubrun O, Simonnet JT, L'alloret F. Nanoemulsions: A new vehicle for skincare products. Advances in colloid and interface science 2004; 108: 145-149
    PubMedGoogle Scholar
  • 33 Hoeller S, Sperger A, Valenta C. Lecithin based nanoemulsions: A comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation. International journal of pharmaceutics 2009; 370: 181-186
    CrossrefPubMedGoogle Scholar
  • 34 Kaur IP, Agrawal R. Nanotechnology: A new paradigm in cosmeceuticals. Recent patents on drug delivery & formulation 2007; 1: 171-182
    CrossrefPubMedGoogle Scholar
  • 35 Patravale VB, Desai PP. Topical Nanointerventions for Therapeutic and Cosmeceutical Applications. In Focal Controlled Drug Delivery. 2014. pp 535-560 Springer US;
    CrossrefGoogle Scholar
  • 36 Lasic DD. Novel applications of liposomes. Trends in biotechnology 1998; 16 (07) 307-321
    CrossrefPubMedGoogle Scholar
  • 37 Kazi KM, Mandal AS, Biswas N. et al. Niosome: a future of targeted drug delivery systems. Journal of advanced pharmaceutical technology & research 2010; 1: 374
    CrossrefPubMedGoogle Scholar
  • 38 Hougeir FG, Kircik L. A review of delivery systems in cosmetics. Dermatologic therapy 2012; 25: 234-237
    CrossrefPubMedGoogle Scholar
  • 39 Gunjan J, Swarnlata S. Topical delivery of Curcuma longa extract loaded nanosized ethosomes to combat facial wrinkles. J Pharm Drug Deliv Res 3 2014; 1: 2
    PubMedGoogle Scholar
  • 40 Saraf S, Jeswani G, Kaur CD. et al. Development of novel herbal cosmetic cream with Curcuma longa extract loaded transfersomes for antiwrinkle effect. African journal of pharmacy and pharmacology 2011; 5: 1054-1062
    PubMedGoogle Scholar
  • 41 Cauchard JH, Bonte F, Archambault JC. inventors; Lvmh Recherche, assignee. Cosmetic composition containing an amber extract. United States patent US 7,887,858. 2011 Feb 15
    PubMed
  • 42 Golz-Berner K, Zastrow L, Moyon R. inventors; Coty BV, assignee. Cosmetic and dermatologic oxygen carrier system. United States patent US 8,252,297. 2012 Aug 28
    PubMed
  • 43 Chung BH, Lim YT, Kim JK et al. inventors; Korea Research Institute Of Bioscience, assignee. Cosmetic pigment composition containing gold or silver nano-particles. United States patent application US 11/995,847. 2006 Feb 13
    PubMed
  • 44 Üner M. Characterization and imaging of solid lipid nanoparticles and nanostructured lipid carriers. In Handbook of Nanoparticles. 2016. pp 117-141 Springer International Publishing;
    CrossrefGoogle Scholar
  • 45 Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced drug delivery reviews 2002; 54: S131-S155
    CrossrefPubMedGoogle Scholar
  • 46 Morales JO, Valdés K, Morales J. et al. Lipid nanoparticles for the topical delivery of retinoids and derivatives. Nanomedicine 2015; 10: 253-269
    CrossrefPubMedGoogle Scholar
  • 47 Vinardell MP, Mitjans M. Nanocarriers for Delivery of Antioxidants on the Skin. Cosmetics 2015; 2: 342-354
    CrossrefPubMedGoogle Scholar
  • 48 Pamudji JS, Mauludin R, Indriani N. Development of Nanostructured Lipid Carrier Formulation containing of Retinyl Palmitate. International Journal of Pharmacy and Pharmaceutical Sciences 2016; 8: 256-260
    PubMedGoogle Scholar
  • 49 Keck C, Schwabe K, Rimpler C. inventors; Pharmasol Gmbh, assignee. Compositions containing lipid micro-or nanoparticles for the enhancement of the dermal actionof solid particles. United States patent application US 13/127,073. 2009 Oct 26
    PubMed
  • 50 Petit JL, Gonzalez RD, Botello AF. inventors; Lipotec SA, assignee. Lipid nanoparticle capsules. United States patent application US 13/636,909. 2011 Mar 24
    PubMed
  • 51 Karami Z, Hamidi M. Cubosomes: Remarkable drug delivery potential. Drug discovery today 2016; 21: 789-801
    CrossrefPubMedGoogle Scholar
  • 52 Chang DP, Barauskas J, Dabkowska AP. et al. Non-lamellar lipid liquid crystalline structures at interfaces. Advances in colloid and interface science 2015; 222: 135-147
    CrossrefPubMedGoogle Scholar
  • 53 Angelova A, Angelov B, Drechsler M. et al. Protein entrapment in PEGylated lipid nanoparticles. International journal of pharmaceutics 2013; 454: 625-632
    CrossrefPubMedGoogle Scholar
  • 54 Hyde S, Blum Z, Landh T. et al. The language of shape: The role of curvature in condensed matter: physics, chemistry and biology. Elsevier; 1996
    Google Scholar
  • 55 Pan X, Han K, Peng X. et al. Nanostructed cubosomes as advanced drug delivery system. Current pharmaceutical design 2013; 19: 6290-6297
    CrossrefPubMedGoogle Scholar
  • 56 Spicer PT. Progress in liquid crystalline dispersions: cubosomes. Current Opinion in Colloid & Interface Science 2005; 10: 274-279
    CrossrefPubMedGoogle Scholar
  • 57 Kwon TK, Lee HY, Dai Kim J. et al. In vitro skin permeation of cubosomes containing water soluble extracts of Korean barberry. Colloid journal 2010; 72: 205-210
    CrossrefPubMedGoogle Scholar
  • 58 Morsi NM, Abdelbary GA, Ahmed MA. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: Development and in vitro/in vivo characterization. European Journal of Pharmaceutics and Biopharmaceutics. 2014; 86: 178-189
    CrossrefPubMedGoogle Scholar
  • 59 Rattanapak T, Birchall J, Young K. et al. Transcutaneous immunization using microneedles and cubosomes: Mechanistic investigations using Optical Coherence Tomography and Two-Photon Microscopy. Journal of controlled release 2013; 172: 894-903
    CrossrefPubMedGoogle Scholar
  • 60 Ribier A, Biatry B. Cosmetic or dermatologic oil/water dispersion stabilized with cubic gel particles and method of preparation. European Patent 0711540B1. 2000 May
    PubMed
  • 61 Albrecht H, Schreiber J. Hair care products with disperse liquid crystals exhibiting the cubic phases. WO Patent 2002041850A1. 2002 May
    PubMed
  • 62 Mainardes RM, Silva LP. Drug delivery systems: past, present, and future. Current drug targets 2004; 5: 449-455
    CrossrefPubMedGoogle Scholar
  • 63 Katz LM, Dewan K, Bronaugh RL. Nanotechnology in cosmetics. Food and Chemical Toxicology 2015; 85: 127-137
    CrossrefPubMedGoogle Scholar
  • 64 Chauhan AS, Sridevi S, Chalasani KB. et al. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. Journal of controlled release 2003; 90: 335-343
    CrossrefPubMedGoogle Scholar
  • 65 Iimura T, Furukawa H. inventors. Copolymer Having Carbosiloxane Dendrimer Structure, And Composition And Cosmetic Containing The Same. United States patent application US 13/517,279. 2010 Dec 22
    PubMed
  • 66 Franzke M, Steinbrecht K, Clausen T et al. inventors; Wella Aktiengesellschaft, assignee. Cosmetic compositions for hair treatment containing dendrimers or dendrimer conjugates. United States patent US 6,068,835. 2000 May 30
    PubMed
  • 67 Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?. Journal of pharmaceutical sciences 2010; 99: 21-50
    CrossrefPubMedGoogle Scholar
  • 68 Crosera M, Bovenzi M, Maina G. et al. Nanoparticle dermal absorption and toxicity: a review of the literature. International archives of occupational and environmental health 2009; 82: 1043-1055
    CrossrefPubMedGoogle Scholar
  • 69 Xiao L, Takada H, Maeda K. et al. Antioxidant effects of water-soluble fullerene derivatives against ultraviolet ray or peroxylipid through their action of scavenging the reactive oxygen species in human skin keratinocytes. Biomedicine & pharmacotherapy 2005; 59: 351-358
    CrossrefPubMedGoogle Scholar
  • 70 Rouse JG, Yang J, Ryman-Rasmussen JP. et al. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Letters. 2007; 7: 155-160
    CrossrefPubMedGoogle Scholar
  • 71 Xia XR, Monteiro-Riviere NA, Riviere JE. Skin penetration and kinetics of pristine fullerenes (C 60) topically exposed in industrial organic solvents. Toxicology and applied pharmacology 2010; 242: 29-37
    CrossrefPubMedGoogle Scholar